215 related articles for article (PubMed ID: 15530838)
1. Different checkpoints in human NK-cell activation.
Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
Trends Immunol; 2004 Dec; 25(12):670-6. PubMed ID: 15530838
[TBL] [Abstract][Full Text] [Related]
2. Surface NK receptors and their ligands on tumor cells.
Moretta L; Bottino C; Pende D; Castriconi R; Mingari MC; Moretta A
Semin Immunol; 2006 Jun; 18(3):151-8. PubMed ID: 16730454
[TBL] [Abstract][Full Text] [Related]
3. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
[TBL] [Abstract][Full Text] [Related]
4. Human NK cell education by inhibitory receptors for MHC class I.
Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E
Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727
[TBL] [Abstract][Full Text] [Related]
5. Cellular ligands of activating NK receptors.
Bottino C; Castriconi R; Moretta L; Moretta A
Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513
[TBL] [Abstract][Full Text] [Related]
6. Do NK-cell receptors and alloreactivity affect solid organ transplantation?
Vilches C; Parham P
Transpl Immunol; 2006 Dec; 17(1):27-30. PubMed ID: 17157210
[TBL] [Abstract][Full Text] [Related]
7. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A.
Salmon-Divon M; Höglund P; Johansson MH; Johansson S; Mehr R
Mol Immunol; 2005 Feb; 42(4):397-403. PubMed ID: 15607790
[TBL] [Abstract][Full Text] [Related]
8. Taking license with natural killer cell maturation and repertoire development.
Parham P
Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883
[TBL] [Abstract][Full Text] [Related]
9. Generation of the natural killer cell repertoire: the sequential vs. the two-step selection model.
Salmon-Divon M; Höglund P; Mehr R
Bull Math Biol; 2003 Mar; 65(2):199-218. PubMed ID: 12675329
[TBL] [Abstract][Full Text] [Related]
10. Unravelling natural killer cell function: triggering and inhibitory human NK receptors.
Moretta L; Moretta A
EMBO J; 2004 Jan; 23(2):255-9. PubMed ID: 14685277
[TBL] [Abstract][Full Text] [Related]
11. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition.
Doucey MA; Scarpellino L; Zimmer J; Guillaume P; Luescher IF; Bron C; Held W
Nat Immunol; 2004 Mar; 5(3):328-36. PubMed ID: 14973437
[TBL] [Abstract][Full Text] [Related]
12. Licensing of natural killer cells by self-major histocompatibility complex class I.
Yokoyama WM; Kim S
Immunol Rev; 2006 Dec; 214():143-54. PubMed ID: 17100882
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.
Johansson S; Johansson M; Rosmaraki E; Vahlne G; Mehr R; Salmon-Divon M; Lemonnier F; Kärre K; Höglund P
J Exp Med; 2005 Apr; 201(7):1145-55. PubMed ID: 15809355
[TBL] [Abstract][Full Text] [Related]
14. Having it both ways: MHC recognition in cis and trans.
Leibson PJ; Pease LR
Nat Immunol; 2004 Mar; 5(3):237-8. PubMed ID: 14985707
[No Abstract] [Full Text] [Related]
15. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
Chen Y; Shi Y; Cheng H; An YQ; Gao GF
IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
[TBL] [Abstract][Full Text] [Related]
16. Natural killer lymphocytes: "null cells" no more.
Moretta A; Bottino C; Sivori S; Marcenaro E; Castriconi R; Della Chiesa M; Carlomagno S; Augugliaro R; Nanni M; Vitale M; Millo R
Ital J Anat Embryol; 2001; 106(4):335-42. PubMed ID: 12003235
[TBL] [Abstract][Full Text] [Related]
17. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
18. How do natural killer cells find self to achieve tolerance?
Yokoyama WM; Kim S
Immunity; 2006 Mar; 24(3):249-57. PubMed ID: 16546094
[TBL] [Abstract][Full Text] [Related]
19. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
[TBL] [Abstract][Full Text] [Related]
20. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
